Viridescent Capital Partners is a global investment management firm focused on making scalable, diversified investments in the cannabis industry.

Viridescent Capital Partners

Acreage Holdings is a multi-state operator in the cannabis industry, providing a suite of distinct brands to serve the needs of cannabis consumers. Self-described as setting industry standards from seed to sale, the company delivers high-quality products.

Acreage Holdings

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include dried cannabis flower, extracts and concentrates, beverages, gummies, and vapes. It offers its products under the Tweed, 7ACRES, 7ACRES Craft Collective, DOJA, Ace Valley, Quatreau, Deep Space, First + Free, Surity Pro, Spectrum Therapeutics, Vert, Tokyo Smoke, Twd, Martha Stewart CBD, DNA Genetics, BioSteel, Storz & Bickel, This Works, HiWay, Simple Stash, Whisl, and Truverra brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation was incorporated in 2009 and is headquartered in Smiths Falls, Canada.

Bruce Linton

Chuck Rifici

Mark Zekulin

Canopy Growth Corporation

HALLEY VP is a cannabis technology venture fund focused on investing early in scalable companies within the legal cannabis and hemp sectors.

HALLEY VP

Viridescent Capital Partners LP | 416 followers on LinkedIn. Viridescent Capital Partners is a private equity firm that brings extensive experience and flexible capital solutions to companies across the cannabis industry. 
 
Our executive team brings more than 60 years of combined capital markets experience and more than 20 years of operating and investing experience in the cannabis industry, making us a credible partner for investors looking to access the cannabis space. 
 
Our deep domain experience and understanding in cannabis make us a powerful ally for companies seeking a partner to foster growth and help facilitate company success through an extensive network that spans the cannabis value chain.

Founder & Chief Investment Officer at Viridescent Capital Partners LP

Kevin Murphy

Strategic Advisor for Viridescent Capital Partners LP

Drew Dawson

Head of Origination and Partner at Viridescent Capital Partners LP

Dennis Byrne

Chief Operating Officer and Partner at Viridescent Capital Partners LP

Dante Domenichelli

Viridescent Capital Partners LP

https://lnkd.in/gQbu_f5e The U.S. government recently proposed rescheduling cannabis from a Schedule I to a Schedule III drug — basically signaling it has some accepted medical use and a moderate to low potential for physical and psychological dependence. But what does this mean in the real world exactly? Sanjay talks with “The Pot Doc” Dr. Staci Gruber, Director of the Marijuana Investigations for Neuroscientific Discovery (MIND) program in Boston, to explore the possible impacts of this rescheduling on research, healthcare, and yes – even you.

Metric
Company Name	Viridescent Capital Partners	Acreage Holdings	Canopy Growth Corporation	HALLEY VP
Symbol			WEED
MSH ID	COM:VIRIDESCENTCAPITAL	COM:ACREAGEHOLDINGS	COM:CANOPYGROWTH	COM:HALLEYVP
Market	PRIVATE	STOCKS	STOCKS	PRIVATE
Sector	Financial Services & Finance	Consumer Goods	Healthcare	Financial Services & Finance
Industry	Investment Management	Cannabis	Drug Manufacturers - Specialty & Generic	Venture Capital
Country	US	US	CA	US
Stage
Employee Count			1.03K
Website	viridescentcapital.com	acreageholdings.com	canopygrowth.com	halleyvp.com
LinkedIn	viridescent-capital-partners-lp		canopy-growth-corporation
Founders

Metric
Market Cap		22.54M	464.00M
Enterprise Value
Monthly Web Traffic	293	5.07K
Web Traffic Growth		0.21
Valuation
Raised Capital

Metric
Revenue			210.20M
Revenue (LTM)
Revenue (NTM)
Gross Profit			57.21M
EBITDA			-62.36M
Operating Income			-161.79M
Net Income			-464.94M
EPS			-6.22
Diluted EPS			-6.22
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin			0.27
Operating Profit Margin			0.14
EBITDA Margin			-0.30
Net Profit Margin			-1.99
Return on Equity			-1.00
Return on Assets			-0.51
Return on Capital Employed			0.04

VIRI

COM:VIRIDESCENTCAPITAL

Viridescent Capital Partners

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio			-3.41
P/B Ratio			5.75
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio			4.30
EV Multiple			5.98

Metric
Days Sales Outstanding			68.47
Days Payables Outstanding			19.26
Days Inventory Outstanding			146.77
Operating Cycle			211.47
Cash Conversion Cycle			167.20
Asset Turnover			0.25

Metric
Operating Cash Flow			-199.45M
Free Cash Flow			-202.27M
Cash Flow to Debt			-0.31
Operating Cash Flow/Sales			-0.64
Free Cash Flow Yield			-0.95

Metric
Cash & Equivalents			120.47M
Accounts Receivable			-2.65M
Inventory			54.67M
Goodwill			30.59M
Debt to Capitalization			0.56
Debt to Assets			0.46
Current Ratio			2.52
Quick Ratio			1.64

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue			0.06
R&D to Revenue			0.03
SG&A to Revenue			0.79